Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy

The Journal of Antimicrobial Chemotherapy
C McNultyK A Cartwright

Abstract

Toxin-producing Clostridium difficile is the commonest bacterial cause of nosocomial diarrhoea and is a well recognized cause of hospital outbreaks in elderly care units. High C. difficile disease rates have been associated with the use of broad-spectrum antibiotics, especially cephalosporins. An outbreak of C. difficile infection in the elderly care unit at Gloucestershire Royal NHS Trust continued despite increased ward cleaning and strict implementation of infection control measures. A restrictive antibiotic policy that would maintain colonization resistance in the gastrointestinal tract was introduced throughout this unit. Patients admitted with suspected infection were prescribed intravenous (i.v.) benzylpenicillin 1.2-1.8 g every 6 h to cover streptococcal infections and i.v. trimethoprim 200 mg twice daily to cover urinary tract pathogens and Haemophilus influenzae. If the patient had septic shock a single iv dose of gentamicin was given (120-180 mg) to cover more resistant gram-negative bacilli. The following were monitored before and after the policy change. The number of cases of C. difficile toxin-positive diarrhoea; cefuroxime and total antibiotic use on the elderly care wards; patient mortality rates; and length of...Continue Reading

Citations

Feb 22, 2012·Irish Journal of Medical Science·A H LavanF Fitzpatrick
May 8, 2004·The Journal of Hospital Infection·UNKNOWN National Clostridium difficile Standards Group
Jul 12, 2003·The Journal of Hospital Infection·R CunninghamN Gaunt
Apr 16, 1999·The Journal of Hospital Infection·T DjureticJ S Brazier
Jul 4, 2001·Gastroenterology Clinics of North America·P R Holt
Jul 18, 2009·International Journal of Antimicrobial Agents·Dale N Gerding
Dec 22, 1999·Microbes and Infection·J Freeman, M H Wilcox
Oct 26, 2000·Current Opinion in Microbiology·S Monroe, R Polk
May 24, 2003·Best Practice & Research. Clinical Gastroenterology·Mark H Wilcox
Jun 10, 2000·Journal of Clinical Pharmacy and Therapeutics·F A Al-EidanM P Kearney
Nov 26, 1999·The New England Journal of Medicine·S L Gorbach
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J L MayfieldL M Mundy
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claudia ThomasThomas V Riley
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H Kollef
Jun 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David B Blossom, L Clifford McDonald
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louis ValiquetteJacques Pépin
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C OwensCarlene A Muto
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale N GerdingRobert C Owens
Aug 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher A Ohl, Elizabeth S Dodds Ashley
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·I M Gould
Oct 6, 2000·The Journal of Antimicrobial Chemotherapy·A GuyotS P Barrett
Feb 25, 2010·The Journal of Antimicrobial Chemotherapy·James D ChalmersJohn H Winter
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Jonathan CookePaul Wade
Oct 13, 2006·Current Opinion in Infectious Diseases·M H Wilcox, N Modi
Feb 19, 2010·Nursing·Kim Delahanty, Frank Myers
Jul 9, 2010·Clinical Microbiology Reviews·J FreemanM H Wilcox
Jun 20, 1998·BMJ : British Medical Journal·S J Wort, T R Rogers
Nov 20, 2001·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Feb 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Carolyn V Gould, L Clifford McDonald
Jul 9, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Susan M Poutanen, Andrew E Simor
May 10, 2001·Journal of the American Veterinary Medical Association·J S WeeseH R Staempfli
Mar 19, 2014·The Journal of Antimicrobial Chemotherapy·Leah M FeazelMarin L Schweizer
Oct 4, 2014·American Journal of Infection Control·Kelly R RevelesChristopher R Frei
Jun 23, 2004·QJM : Monthly Journal of the Association of Physicians·K A O'ConnorD O'Mahony
May 26, 2011·Critical Reviews in Microbiology·Melina Kachrimanidou, Nikolaos Malisiovas
Mar 4, 2014·Expert Review of Anti-infective Therapy·Camilla WiuffJohn E Coia
Oct 17, 2013·Enfermedades infecciosas y microbiología clínica·Benito AlmiranteJesús Rodríguez-Baño
Feb 15, 2011·Infectious Disease Clinics of North America·Courtney Hebert, Stephen G Weber
Dec 7, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Eleni ApostolopoulouIoannis Elefsiniotis
Aug 12, 2009·Infectious Disease Clinics of North America·Mary C Barsanti, Keith F Woeltje

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.